Author:
Molife L R,Fong P C,Paccagnella L,Reid A H M,Shaw H M,Vidal L,Arkenau H-T,Karavasilis V,Yap T A,Olmos D,Spicer J,Postel-Vinay S,Yin D,Lipton A,Demers L,Leitzel K,Gualberto A,de Bono J S
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Abe S, Funato T, Takahashi S, Yokoyama H, Yamamoto J, Tomiya Y, Yamada-Fujiwara M, Ishizawa K, Kameoka J, Kaku M, Harigae H, Sasaki T (2006) Increased expression of insulin-like growth factor 1 is associated with Ara-C resistance in leukemia. Tohoku J Exp Med 209: 217–228
2. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10: 6897–6904
3. Benini S, Manara MC, Baldini N, Cerisano V, Massimo S, Mercuri M, Lollini PL, Nanni P, Picci P, Scotlandi K (2001) Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells. Clin Cancer Res 7: 1790–1797
4. Carden CP, Molife LR, de Bono JS (2009) Predictive biomarkers for targeting insulin-like growth factor receptor type I. Mol Cancer Ther 8: 2077–2078
5. Cardillo MR, Monti S, Di Silverio F, Gentile V, Sciarra F, Toscano V (2003) Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. Anticancer Res 23: 3825–3835
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献